| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/07/2005 | US20050074836 Containing modifications in the A3 and/or C1 and/or C2 domains of the sequence of the light chain of Factor VIII |
| 04/07/2005 | US20050074818 Methods and agents for the diagnosis and therapy of chronically inflammatory intestinal diseases |
| 04/07/2005 | US20050074814 Relaxin3-GPCR135 complexes and their production and use |
| 04/07/2005 | US20050074808 Transmembrane receptor (CON 167) for use as tool in detecting modulators for treatment and prevention of nervous system disorders |
| 04/07/2005 | US20050074807 Heterogeneous nuclear ribonucleoprotein overexpression for use as diagnostic/prognostic tool in detection of cell proliferative disorders |
| 04/07/2005 | US20050074805 Specific markers for diabetes |
| 04/07/2005 | US20050074802 Nucleotide sequences which code for the MetD gene |
| 04/07/2005 | US20050074797 FHIT proteins and nucleic acids and methods based thereon |
| 04/07/2005 | US20050074794 labeling proteins and other molecules such as lipid and carbohydrates in different samples, then combining these samples for concurrent analysis, for reliable qualitative and quantitative comparison between the samples |
| 04/07/2005 | US20050074791 L-lysine-producing corynebacteria and process for the preparation of L-lysine |
| 04/07/2005 | US20050074790 Methods for using chemokine teck |
| 04/07/2005 | US20050074777 Novel cell-surface estrogen receptor and related compositions and methods |
| 04/07/2005 | US20050074770 Cloned mammalian histamine H4 receptor that couples to G-protein; for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 04/07/2005 | US20050074768 Monoclonal, polyclonal or neutralizing antibody or a antigen-binding Fab, Fc, F(ab)2, or Fv fragment that specifically binds to a histamine receptor having a specific sequence; may have a radiolabel, a fluroescent label, a chemiluminescent label, or an enzymatic label |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074766 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074763 Denaturat stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074756 FALP proteins |
| 04/07/2005 | US20050074755 Nucleotide sequences coding mutator locus gene for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 04/07/2005 | US20050074754 Membrane protein for use in diagnosis, treatment and prevention of inflammation; immunosuppressants |
| 04/07/2005 | US20050074752 Expression vector comprising nucleotide sequences coding viral regulatory protein for use in transformation of muscle cell and generating vaccine for prevention of viral infection |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074750 Using multi-epitope antigen to diagnose viral and micoorganismal infection |
| 04/07/2005 | US20050074749 Method for the identification of extracellular domains of the epstein barr virus (ebv), tumor-associated latent membrane proteins and for the selection of antibody reagents reactive therewith |
| 04/07/2005 | US20050074747 Identifying peptide sequences that selectively bind to preferential bio-targets for use in diagnosis of viral disease, diabetes, inflammatory, arthritic, atherosclerotic, cell proliferative, autoimmune and cardiovascular disorders |
| 04/07/2005 | US20050074465 HCV fusion proteins with modified NS3 domains |
| 04/07/2005 | US20050074464 Type I allergic diseases; grass pollen |
| 04/07/2005 | US20050074462 Suppressing IgE immunoglobulin mediated hypersensitivity; transdermal administration |
| 04/07/2005 | US20050074459 Escherichia coli O157:H7 epithelial adhesin |
| 04/07/2005 | US20050074458 Omp85 proteins of neisseria gonorrhoeae and neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/07/2005 | US20050074457 Simplified, high throughput screening for identification of heat shock protein 90 ligands selective for high affinity form |
| 04/07/2005 | US20050074454 Methods of treating carcinoma using anti-TNF antibodies and peptides |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074426 A conjugate of a cytokine and a tumor targeting moiety with numerous provisos |
| 04/07/2005 | DE10341812A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2540706A1 Royal jelly peptide and composition containing the same |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540644A1 A method of modulating cell survival, differentiation and/or synaptic plasticity |
| 04/07/2005 | CA2540446A1 Polypeptide cleavage method using ompt protease variant |
| 04/07/2005 | CA2540331A1 Fractal-forming alkylketene dimers for integral membrane protein crystal growth |
| 04/07/2005 | CA2540283A1 Tumor vaccine |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | CA2540006A1 Treating inflammation using a biological agent that causes cells to release cytokine receptors |
| 04/07/2005 | CA2539972A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | CA2539918A1 Vege-cor vege-d materials and methods for stimulation of neural stem cells |
| 04/07/2005 | CA2539864A1 Hiv pharmaccines |
| 04/07/2005 | CA2539837A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2539709A1 Novel therapeutic targets in cancer |
| 04/07/2005 | CA2539596A1 Melanocortin receptor agonists |
| 04/07/2005 | CA2537876A1 Antibodies to m-csf |
| 04/07/2005 | CA2537340A1 Leader sequences for use in production of proteins |
| 04/06/2005 | EP1520861A1 Test system for the identification of APJ receptor ligands |
| 04/06/2005 | EP1520860A2 Recombinant protein PilC, method for its production and use thereof |
| 04/06/2005 | EP1520859A2 Hydrophilic signal oligopeptides and methods of therapeutic use |
| 04/06/2005 | EP1520589A1 Erythropoietin in the treatment of domestic and livestock animals for anaemia |
| 04/06/2005 | EP1520050A2 Tr4/tr2 response elements |
| 04/06/2005 | EP1520036A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/06/2005 | EP1520025A2 Nucleic acid molecules involved in the synthesis of melithiazols |
| 04/06/2005 | EP1520024A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 04/06/2005 | EP1520023A2 Human nuclear hormone receptor |
| 04/06/2005 | EP1520022A2 Rna-interference by single-stranded rna molecules |
| 04/06/2005 | EP1520019A2 Adapter-directed display system |
| 04/06/2005 | EP1520016A1 Human receptor tyrosine kinase mertk |
| 04/06/2005 | EP1520014A2 Tocopherol associated protein and uses thereof |
| 04/06/2005 | EP1519979A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 04/06/2005 | EP1519958A2 Humanized monoclonal antibody hpam4 |
| 04/06/2005 | EP1519957A2 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 04/06/2005 | EP1519955A2 Nuclear hormone receptor |
| 04/06/2005 | EP1519954A1 Ligand binding domains of nuclear hormone receptors |
| 04/06/2005 | EP1519953A1 Avian cytokines, such il-12, comprising a p40 and/or p35 subunit(s) |
| 04/06/2005 | EP1519951A2 Cationic linear peptides having antibacterial and/or antifungal properties |
| 04/06/2005 | EP1519950A2 Components of the presenilin-complex |
| 04/06/2005 | EP1519949A1 Variants of the house dust mite allergen der f2 |
| 04/06/2005 | EP1519948A1 Gene for increased somatic recombination |
| 04/06/2005 | EP1519947A1 Vegetable protein preparations and use thereof |
| 04/06/2005 | EP1519946A2 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/06/2005 | EP1519944A1 Processes for the preparation of fibrinogen |
| 04/06/2005 | EP1519942A2 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 04/06/2005 | EP1519744A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins |
| 04/06/2005 | EP1519743A1 Use of an interleukin 1 receptor antagonist and/or pyrrolidinedithiocarbamate for the treatment or prophylaxis of type 2 diabetes |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519741A2 Proteins associated with cells growth, differentiation and death |
| 04/06/2005 | EP1519737A2 Fibrin nanoparticles and uses thereof |
| 04/06/2005 | EP1519735A2 Assays and implements for determining and modulating hsp90 binding activity |
| 04/06/2005 | EP1519650A2 Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism |
| 04/06/2005 | EP1420630A4 Stress-related polynucleotides and polypeptides in plants |
| 04/06/2005 | EP1406918A4 The production of soluble keratin derivatives |
| 04/06/2005 | EP1360282B1 Method for inactivation of TSE |
| 04/06/2005 | EP1326983B1 Gene cluster for ramoplanin biosynthesis |
| 04/06/2005 | EP1284997B1 Therapeutic compounds for ovarian cancer |
| 04/06/2005 | EP1276754A4 Materials and methods relating to lipid metabolism |
| 04/06/2005 | EP1237936B1 Molecularly imprinted polymers produced by template polymerisation |
| 04/06/2005 | EP1230345A4 Environmental stress tolerance genes |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1212618A4 Effect of steroids on nmda receptors depends on subunit composition |